Gastric Ulcers Clinical Trials

A listing of Gastric Ulcers medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 7 clinical trials
A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Gu rin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

The purpose of this study is to evaluate recurrence-free survival (RFS) in participants treated with erdafitinib vs Investigator's Choice, for participants with high-risk non-muscle-invasive bladder cancer (NMIBC) who harbor fibroblast growth factor receptor (FGFR) mutations or fusions, and who recurred after bacillus calmette-guerin (BCG) therapy.

transitional cell carcinoma
human chorionic gonadotropin
cancer
carcinoma
bladder tumor
  • 0 views
  • 26 Jul, 2021
  • 199 locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

cell carcinoma with variants of penis (closed to accrual) Squamous cell carcinoma variants of the genitourinary (GU) system Spindle cell carcinoma of kidney, pelvis, ureter

gilbert's syndrome
bone scan
stromal tumor
immunosuppressive
parathyroid
  • 6047 views
  • 01 Aug, 2021
  • 815 locations
A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis Gastric Ulcer or Duodenal Ulcer

have a documented medical history of gastric ulcer or duodenal ulcer diagnosis. Doses of D961H in this study is set for the 2 groups (weight more than equal 10 kg to less than 20 kg and weight

aspirin therapy
proton pump inhibitors
esophagogastroduodenoscopy
maintenance therapy
gastric ulcer
  • 518 views
  • 24 Jul, 2021
  • 16 locations
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that have spread to other places in

nivolumab
transitional cell carcinoma
corticosteroids
brain metastases
squamous cell carcinoma
  • 191 views
  • 01 Aug, 2021
  • 474 locations
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

, gastrointestinal (GI), primary unknown, genitourinary (GU), sarcoma, gynecological, and 'other' cancer types. Participants in all cohorts will receive the same dose of atezolizumab (1200 mg every 3 weeks). In the

gilbert's syndrome
absolute neutrophil count
serum bilirubin
liver metastasis
neutrophil count
  • 0 views
  • 23 Jul, 2021
  • 1 location
Coping Together: Couple-based Interventions for Cancer

The objective of the proposed study is to evaluate the Couple Communication Skills Training (CCST) intervention in 250 patients with advanced cancer and their spouses/intimate partners. Couples will be randomized 1:1 to receive either the CCST or to an attention control condition (Healthy Living Information; HLI). We will evaluate CCST …

  • 0 views
  • 22 Jul, 2021
  • 1 location
Head Yuanshi Dian Therapy in Burning Mouth Syndrome

Burning mouth syndrome is one of the most common oral mucosal diseases in clinic. It is a chronic pain syndrome with extensive burning pain of oral mucosa as its main symptoms. There are no pathological changes in oral mucosa and no characteristic histopathological changes. Patients often have accompanying symptoms such …

  • 0 views
  • 25 Jul, 2021
  • 3 locations